Viewing Study NCT04919369


Ignite Creation Date: 2025-12-24 @ 10:50 PM
Ignite Modification Date: 2026-02-03 @ 5:08 AM
Study NCT ID: NCT04919369
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-11-10
First Post: 2021-06-03
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: All-Trans Retinoic Acid (ATRA) and Atezolizumab for the Treatment of Recurrent or Metastatic Non-Small Cell Lung Cancer
Sponsor: Dwight Owen
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Metastatic Lung Non-Small Cell Carcinoma View
None Recurrent Lung Non-Small Cell Carcinoma View
None Stage IV Lung Cancer AJCC v8 View
None Stage IVA Lung Cancer AJCC v8 View
None Stage IVB Lung Cancer AJCC v8 View
Keywords: